nature neurOSCIenCe a r t I C l e S In mammals, olfactory sensation starts with the detection of odor ligands predominantly by ORs, a large family of seven transmembrane G protein-coupled receptors (GPCRs) 1,2 . ORs are individually expressed in olfactory sensory neurons (OSNs) located in the olfactory epithelium (OE). The mouse genome encodes over 1,000 intact ORs 2 . Odor recognition follows a combinatorial coding scheme, where one OR can be activated by a set of odorants and one odorant can activate a combination of ORs 3,4 . Through such combinatorial coding, mammals can detect and discriminate a large number of olfactory stimuli.
a r t I C l e S
In mammals, olfactory sensation starts with the detection of odor ligands predominantly by ORs, a large family of seven transmembrane G protein-coupled receptors (GPCRs) 1, 2 . ORs are individually expressed in olfactory sensory neurons (OSNs) located in the olfactory epithelium (OE). The mouse genome encodes over 1,000 intact ORs 2 . Odor recognition follows a combinatorial coding scheme, where one OR can be activated by a set of odorants and one odorant can activate a combination of ORs 3, 4 . Through such combinatorial coding, mammals can detect and discriminate a large number of olfactory stimuli.
Deciphering the coding of olfactory information requires the comprehensive identification of ORs that respond to a given odorant 5 . Various in vivo, ex vivo and in vitro methods, such as virus-mediated OR overexpression 6, 7 , calcium imaging of dissociated OSNs combined with singlecell RT-PCR 3, 7 , the use of fluorescently labeled transgenic mice 8 and in vitro OR expression 9 have been used to match ORs with their cognate ligands. Notably, molecular receptive range analyses of a few ORs have revealed diverse odor tuning properties among the tested ORs 10, 11 .
Currently, large-scale identification of active ligands for mammalian ORs relies on in vitro heterologous cell systems 4, 9, 12 . Though many studies, including those of M71, M72, I7, OR-EG, MOR23 and SR1 in mice, and OR7D4, OR11H7, OR5A1, OR2J3 and OR10G4 in humans, have shown that in vitro responses predict OSN activation in mice and odor perception in humans [12] [13] [14] [15] [16] , the lack of highthroughput in vivo mapping methods makes it difficult to estimate the correspondence between in vitro and in vivo results across a large number of ORs activated by a given odor.
The S6 ribosomal subunit is phosphorylated following neuronal activation 17 . This phosphorylation is comparable to induction of immediate early gene expression, such as c-Fos and Egr-1, which is widely used to mark active neurons 15, 18, 19 . However, unlike immediate early gene expression, phosphorylated S6 has the advantage of being physically associated with mRNA species expressed in the activated neurons. Thus, phospho-S6 immunoprecipitation (pS6-IP) followed by mRNA profiling with RNA-Seq has been developed as a method to identify mRNAs expressed in activated neurons 17 . This approach has been successfully applied in brain regions such as the hypothalamus to identify markers of neurons that respond to feeding, starvation and high salt 17 .
We found that S6 phosphorylation occurs in the mouse OE following odor stimulation and is a reliable marker for OSN activation. pS6-IP revealed enrichment in subsets of OR mRNAs in mice stimulated with odorants. Using both high-throughput in vivo mapping and in vitro validation, we identified diverse sets of ORs responding to acetophenone and TMT.
RESULTS
Odor exposure leads to S6 phosphorylation in the OE In the OE, each OSN chooses to express one OR allele out of over 1,000 possible OR genes 3, 20 . Thus, we reasoned that pS6-IP could be applied in the olfactory system to map odor-activated ORs, as ORs associated with activated OSNs would likely be responding to the odor. However, it is unknown whether ribosome phosphorylation occurs in the OSNs activated by odor exposure and, if so, whether pS6-associated ORs respond to the tested odor. To determine whether S6 phosphorylation occurs when ORs are activated in the OSNs, we first tested whether odor stimulation leads to S6 phosphorylation in the OE. We presented each of the tested mice with a stimulation cassette a r t I C l e S enclosing a piece of filter paper spotted with 10 µl undiluted (100%) or 1% acetophenone (odor), or distilled water (control) in a clean disposable cage. We killed the animals 1 h later and stained coronal sections from the OE with anti-pS6 antibody (Fig. 1a) . Although the background pS6 signal was low in the control OE, a subpopulation of OSNs in the stimulated OE displayed strong staining for pS6 (fraction of OSNs showing positive pS6 staining following stimulation with 100% acetophenone: 16 ± 3%, n = 3 images; 1% acetophenone: 6 ± 2%, n = 3 images). Double staining with an antibody against a known acetophenone receptor, Olfr160, also known as M72 (the related acetophenone receptor M71 is a pseudogene in C57BL/6 strain), revealed colocalization of Olfr160 and pS6 signals, suggesting that Olfr160-expressing OSNs show S6 phosphorylation in response to acetophenone stimulation. To determine the specificity of pS6 induction 0%  1%  100%  0%  1%  100%  0%  1%  100%  0%  1%  100%  0%  1% Fig. 1a ) and quantified the proportion of Olfr160-expressing OSNs that showed pS6 staining. As expected, odor stimulation with Olfr160 agonists (methyl salicylate, methyl benzoate, acetophenone) led to S6 phosphorylation in a large proportion of Olfr160-expressing OSNs, whereas, in animals stimulated by control odors (heptanoic acid, TMT, (+)-carvone), pS6 signals showed little overlap with Olfr160 signals (Fig. 1b and Supplementary Fig. 1b) .
To further evaluate the specificity and sensitivity of the pS6 method, we quantified pS6 induction using staining intensity for five known OR-odorant pairs, including Olfr690 (MOR31-2, isovaleric acid) 22 , Olfr961 (MOR224-5, eugenol) 22 , Olfr2 (I7, heptanal) 6, 8, 23 and Olfr1440 (MOR215-1, muscone) 15, 24 , in addition to Olfr160 (M72, acetophenone) and control pairs of ORs with non-activating odorants. Three ORs were dorsally expressed (Olfr160, Olfr690 and Olfr961) and two were ventrally expressed (Olfr2 and Olfr1440). We stimulated individual mice with one of the odorants (10 µl, undiluted) and performed in situ hybridization with each of the five OR probes followed by pS6 immunostaining (Fig. 1c,d and Supplementary  Fig. 2a ). When we quantified pS6 signal intensities in individual OSNs labeled with each of the OR probes, significant pS6 induction was observed with previously reported OR-odorant pairs compared with control OR-odorant combinations (P < 0.0001, one-way ANOVA and Dunnett's post hoc test). When we tested the ORs with two different concentrations (100% and 1%) of cognate odorants, significant pS6 induction was observed (P < 0.001, one-way ANOVA and Dunnett's post hoc test), with the exception of Olfr961 with 1% eugenol (Fig. 1e, Supplementary Fig. 3 Fig. 2b ). These results suggest that pS6 is a reliable marker for OSN activation following odor stimulation.
pS6-IP enriches OR mRNAs following odor stimulation
To more comprehensively identify the ORs expressed in the pS6-positive OSNs, we performed pS6-IP followed by RNA-Seq (Fig. 2a) . Three pairs of mice, each consisting of littermates of the same gender and age, were used for each pS6-IP RNA-Seq experiment. In each pair, mice were exposed to either acetophenone or no odor control. We dissected the OE 1 h later, homogenized the tissue, immunoprecipitated pS6 along with associated RNAs and analyzed the purified RNA. Comparison of the samples from mice stimulated with 10 µl of acetophenone versus control revealed a higher level of the immediate early genes c-Fos and Egr1 in the stimulated samples, suggesting that pS6-IP enriches mRNA species in activated OSNs (Fig. 2b) . We measured expression levels for ORs by counting reads that mapped to coding exons of OR transcripts. Although the vast majority of genes were expressed at comparable levels in the two groups, a subset of ORs was enriched in the stimulated group. Differential expression analysis identified a large set of ORs, including Olfr160 (M72), that were significantly enriched following stimulation with 10 µl of undiluted (100%) acetophenone (47 and 75 ORs with P < 0.001 and P < 0.05, respectively, false discovery rate (FDR) adjusted; Fig. 2c,d) . Stimulation with 10 µl of 1% acetophenone (Fig. 2e,f ) enriched 9 and 25 ORs (P < 0.001 and P < 0.05, respectively, FDR adjusted). Most of these ORs were also enriched following 100% acetophenone stimulation (9 of 9 for ORs enriched with P < 0.001, 14 of 25 for ORs enriched with P < 0.05; Fig. 2g) , suggesting that the enrichment process is reproducible and is consistent with previous findings that high odor concentrations activate additional ORs 3, 25 . Enriched ORs tend to respond to acetophenone in vitro To confirm that the in vivo receptor mapping identified acetophenoneactivated ORs, we leveraged the previously established cAMP-mediated luciferase reporter gene assay in heterologous cells 26, 27 to measure the response of these ORs to acetophenone (Fig. 3a) . To systematically test whether the enriched ORs are more likely to respond to acetophenone, we tested 71 ORs enriched by 100% acetophenone (of 75 ORs with P < 0.05 after FDR correction) and 449 control ORs that were not enriched (Fig. 3b) . We independently expressed these ORs in Hana 3A cells, which are an HEK293T-derived cell line that supports the robust expression of various transiently expressed ORs 9, 26 , and stimulated the cells with 3 µM, 30 µM or 300 µM of acetophenone as well as no-odor controls. We quantified the degree of OR activation by determining the relative fold-increase of luciferase activity as compared with control stimulation. As expected, acetophenone-induced in vitro activation of enriched ORs was higher than that of control ORs (P = 0.005 at 30 µM, P = 7 × 10 −21 at 300 µM, Wilcoxon rank-sum test; Fig. 3c) . Similarly, the ORs that were activated by acetophenone in vitro were enriched in the pS6-IP analysis as a group (P = 10 −14 , Wilcoxon rank-sum test; Fig. 3d ). The cut-off for defining positive response to acetophenone in vitro was a 2.33-fold increase in luciferase induction at 300 µM (see Online Methods for the determination of the cut-off, which was set to exclude 99% of negative receptors). Of the 75 ORs enriched in the 100% acetophenone experiment (P < 0.05), 71 ORs were tested in vitro and 69% (49 ORs) responded. In contrast, of the 1,047 ORs not enriched by 100% acetophenone (P > 0.05), 449 ORs were tested in vitro and only 13% (58 ORs) responded. 74% (43 ORs) of these 58 ORs showed trends of enrichment in vivo, but did not reach statistical significance. To quantify how well our in vivo and in vitro results predict each other, we generated receiver operating characteristic (ROC) curves by plotting the true positive rate against the false positive rate as the discrimination cut-off of the predictor is varied. Enrichment in pS6-IP RNA-Seq predicted whether the OR responded to acetophenone in vitro (area under the ROC curve (AUC) = 0.754, P = 6 × 10 −16 , Wilcoxon rank-sum test, one tailed against H 0 : classifier performs no better than random; Fig. 3e ).
In vitro response also predicted the P value of enrichment in pS6-IP RNA-Seq (AUC = 0.845, P = 7 × 10 −21 , Wilcoxon rank-sum test, one tailed against H 0 : classifier performs no better than random; Fig. 3f ).
Identification of acetophenone ORs
After establishing the concordance between in vivo and in vitro responses, we set out to further investigate the acetophenoneactivated ORs. We selected ORs that were enriched in the S6 phosphorylation analysis with acetophenone, expressed these ORs in npg a r t I C l e S Hana3A cells 9 and challenged the cells with 10 −9 to 10 −3 M acetophenone. The dose-dependent luciferase response profiles confirmed that 48 ORs were indeed activated by acetophenone (Fig. 4a,b) . Of the 75 ORs enriched in 100% acetophenone experiment (P < 0.05), 71 were tested in vitro and 45 (63%) responded. Of the 25 ORs enriched in 1% acetophenone experiment (P < 0.05), 24 were tested in vitro and 15 (63%) responded. Of the 15 confirmed acetophenone ORs identified for 1% acetophenone, 12 (80%) were also enriched by 100% acetophenone, whereas the other three did not reach statistical significance, although they showed trends toward enrichment. The 1% and 100% stimulation experiments thus identified at total of 48 acetophenone receptors (Supplementary Table 2 ). We reasoned that these 48 receptors, supported by both in vivo and in vitro evidence, are likely to be bona fide acetophenone receptors. To confirm that the acetophenone ORs that we identified do respond to acetophenone in vivo, we performed pS6 staining along with fluorescent RNA in situ hybridization using specific probes for six of the newly identified acetophenone ORs and a control OR that showed no in vitro response or enrichment in pS6-IP. Indeed, acetophenone exposure resulted in pS6 induction in OSNs expressing identified acetophenone ORs as compared with the control OR (Fig. 4c,d and Supplementary Fig. 3) .
Although the binary responses of in vivo and in vitro results correlate well, the extent to which the pS6 method captures the information of OR sensitivity is not clear. To address this question, we plotted the in vitro EC 50 values against the in vivo fold of transcript enrichment for the 48 acetophenone ORs. Indeed, EC 50 value negatively correlated with transcript fold change on log scales following 1% acetophenone stimulation (P = 0.005, linear regression and ANOVA, Spearman's rho = −0.395; Fig. 5a ), suggesting that ORs more sensitive in vitro tend to be more enriched in vivo. However, this correlation was not observed for the 100% acetophenone stimulation (P = 0.993, linear a r t I C l e S regression and ANOVA, Spearman's rho = 0.00137; Fig. 5b ), presumably as a result of saturation of the olfactory signaling pathways in OSNs following high-intensity odor stimulation. Consistent with this, the set of ORs enriched by 1% acetophenone tended to contain a higher fraction of more sensitive ORs as compared with ORs not enriched or enriched only by 100% acetophenone (P < 2 × 10 −16 , Chi-square test; Fig. 5c ). In addition, the median EC 50 value of ORs enriched by 1% acetophenone tended to be lower than that of those only enriched by 100%, although these results were not statistically significant (P = 0.207, Wilcoxon rank-sum test; Fig. 5d ). These results suggest that, although pS6-IP with high odorant concentrations is useful for capturing the maximum number of responding ORs, lower odorant concentrations better preserve information regarding OR sensitivity to the odorant.
Sequence-function relationship of acetophenone ORs
Having a large set of acetophenone ORs, we next asked whether these ORs have greater overall homology with each other. To our surprise, when we plotted the acetophenone ORs on the OR phylogenetic tree, they were not clustered in one or a few subfamilies, although there were a few notable examples of closely related ORs (Fig. 6a) . Rather, their sequences were markedly diverse: at least one member of 29 of the 286 receptor families defined previously 28 were represented. Even though their overall sequences are diverse, it is possible that particular domains or sites are shared among acetophenone ORs. We therefore asked whether particular amino acid residues were conserved at a given site among the acetophenone ORs as a group.
Comparison of mean Grantham distances 29 of amino acid properties at individual sites among the acetophenone ORs with that of random OR sets identified 44 sites with higher amino acid similarity among acetophenone 
npg a r t I C l e S
ORs than would be expected by random chance (n = 44, P < 0.05, n = 17, P < 0.01, FDR adjusted; Fig. 6b and Supplementary Fig. 4 ; see Online Methods for details). Notably, these sites are not highly conserved among ORs as a whole and the majority of them are located in transmembrane helices implicated in odorant binding. The conserved sites among acetophenone ORs indicate that primary protein sequences may contain sufficient information to predict whether or not a given OR responds to acetophenone. Indeed, a principal component analysis on the amino acid properties 29 of ORs identified four clusters using the first three principal components, and the acetophenone ORs were mainly present in one of them (Fig. 6c) . To build models linking OR protein sequences to their responsiveness to acetophenone, we took two different approaches and tested them in both tenfold cross-validation and external validation schemes. The data for modeling contained the 48 ORs that we identified as acetophenone receptors and 367 ORs that showed no significant response to acetophenone both in vivo and in vitro. The first model was built using the support vector machine (SVM) with radial basis kernel, as commonly used in the machine learning community 30 . Briefly, the SVM algorithm finds the hyper surface in the parameter space that best separates the ORs responding and not responding to acetophenone. A second model was built using logistic regression with variable selection using elastic net penalty 31 . The variable selection step was introduced to reduce over-fitting. As a comparison, we also implemented a classifier using the overall sequence similarity to predict OR responses. All of the models were tested in a tenfold cross-validation scheme. In addition, we also obtained the in vitro acetophenone response profiles of 27 human ORs and used this separate data set for external validation of models (Supplementary Fig. 5 ). These human ORs were functionally expressed in our heterologous system successfully to exclude confounding factors such as failures of functional expression in vitro 12 . Indeed, the SVM and elastic net models showed significant predictive values in both cross (P = 10 −120 , P = 3 × 10 −97 ) and external (P = 0.04, P = 0.04) validation and correctly predicting responsiveness to acetophenone 71.6-81.5% of the time. In contrast, the overall similarity based approach did not predict responsiveness to acetophenone with statistical significance (P = 0.1, P = 0.1; Fig. 6d,e and Table 1 ).
Identification of TMT ORs
We used acetophenone to comprehensively identify OR repertoire, but whether the method can be used for other odorants is not clear. We chose the odor TMT, a fox feces component that induces fear-related responses in predator-naive mice 32, 33 . We next applied our OR mapping protocol to identify ORs responsible for detecting TMT in vivo. We stimulated mice with 100% TMT for 1 h and performed pS6-IP on the dissected OE (n = 4 pairs). TMT stimulation led to enrichment of 43 ORs (P < 0.05). 1% TMT enriched 4 ORs (P < 0.05), a subset of the 43 100% TMT-enriched ORs (Fig. 7a and Supplementary Fig. 6 ). We cloned 42 of these ORs, and 21 of them displayed significant responses to TMT when expressed in vitro (Fig. 7b) . Thus, we found strong evidence that these 21 ORs are indeed TMT receptors (Supplementary Table 2 ). Somewhat unexpectedly, six of the TMT ORs were also npg a r t I C l e S identified as acetophenone receptors. Similar to acetophenone ORs, the TMT ORs were also diverse in sequence (Fig. 7c) . Similar to the majority of conserved residues among acetophenone ORs, the conserved residues among TMT ORs were also located in transmembrane helices, and may have been involved in ligand binding (Fig. 7d) . Five of these TMT ORs (Olfr20, Olfr30, Olfr57, Olfr376 and Olfr491) were expressed in the dorsal OE, a region implicated in mediating the fear-related behavioral responses of TMT 33 (Supplementary Fig. 6e ). These ORs represent candidates for future investigation to understand the basis of TMT-induced behaviors. Together, our data suggest that pS6-IP in combination with RNA-Seq can be used to identify active ORs for diverse odorants. 24 . Three ORs were identified for eugenol and two ORs for muscone, supported by both in vivo and in vitro methods. The Kentucky assay may be suitable for identifying the ORs that are the most active, whereas our pS6-IP method enables the large-scale identification of ORs for a given odor. As compared with S100a5-tauGFP, pS6 induction showed faster onset (30 min to 1 h versus 14 h of odor stimulation time). In addition, pS6-IP does not require specific transgenic animals, which may enable researchers using non-model species to identify ORs activated by odorants of interest. In this issue, Von der Weid et al. 34 report a method that takes advantage of the decrease in OR transcript abundance following odor stimulation to identify ORs responding to acetophenone and ethyl isobutyrate 34 . As compared with pS6-IP, this method involves fewer steps and only requires working with whole RNA from OE, whereas pS6 induction occurs much faster than downregulation of OR transcripts. We examined the set of acetophenone ORs (n = 22) identified by von der Weid et al. 34 in our pS6-IP RNA-Seq and heterologous expression data. 20 of 22 (91%) ORs showed positive log fold change at least one concentration, of which 18 (81%) ORs were significantly enriched (P < 0.05, FDR adjusted for 22 ORs) at least in one concentration. In addition, 15 of 17 (88%) ORs showed in vitro activation. Overall, 21 of 22 (95%) ORs were supported by at least one of the criteria in our data set (Supplementary Table 3) . Quantification by generating an ROC curve revealed that enrichment in pS6-IP RNASeq predicted the ORs identified by von der Weid et al. 34 (AUC = 0.86, P = 4 × 10 −9 , Wilcoxon rank-sum test, one tailed against H 0 : classifier performs no better than random; Supplementary Fig. 7) . Together, our data support the findings of von der Weid et al. 34 as groups. The different stimulation conditions, different signaling pathways and kinetics underlying these two methods, as well as method-specific statistical cutoffs for defining positive receptors, likely contribute to the differences in outcome. Future research is necessary to clarify why certain ORs were only identified in one of the two methods.
DISCUSSION
In general, we found high correlations between in vivo and in vitro mapping results, strongly suggesting that OR activation leads to phosphorylation of S6. Future study will be necessary to identify the signaling pathway leading to S6 phosphorylation. Our quantification of pS6 immunostaining signal intensity suggests that both ligand concentrations and ligand affinities for each OR influence phosphorylation levels of S6. Although higher phosphorylation levels are usually associated with higher concentrations of a given ligand, the levels may saturate for high-affinity receptors.
We established a stringent criteria requiring both in vivo and in vitro support to determine ORs activated by a given odorant. Nonetheless, there are some discrepancies between in vivo and in vitro OR activity worth addressing in the future. One possible explanation for these differences is that odor molecules are converted into other chemicals in the nasal mucus and activate additional ORs 35, 36 . Another possibility is poor functional expression of some ORs in vitro. Although unlikely, one also cannot exclude the possibility that some OSNs express multiple ORs at high levels, in which case non-responding ORs may be enriched if the coexpressed OR responded to the odor. Finally, the statistical definitions of activation and enrichment used may not fully capture the biological significance. Increasing the sequencing depth (currently ~10,000,000 reads per sample) might give more reads to better test against the null hypothesis for ORs less frequently chosen and expressed at low levels in the OE. Despite these potential shortcomings, our method represents a powerful strategy for identifying active ORs for an odor of interest.
We found good correlation between in vitro sensitivities and in vivo enrichment at a low stimulation concentration. Differences between the in vivo and in vitro systems may help to explain the noise in this correlation. For instance, the anatomical structure of the nasal passage can influence airflow, which in turn can affect the odorant concentration dissolved in the nasal mucus 37 . Because ORs are expressed in a zonal pattern in the olfactory epithelium, the exact odorant concentration each OR is exposed to can vary. Furthermore, the existence of odorant-binding proteins in the nasal mucus may also change the kinetics of OR-odorant interactions. In contrast, we did not see correlation between in vitro sensitivities and in vivo enrichment at a high stimulation concentration. It is possible that, for many olfactory neurons, the olfactory signaling pathways are saturated by the high concentration of ligand regardless of OR sensitivity.
Higher concentrations of a given odor not only increase the perceived odor intensity, but may affect the perceived odor quality in some cases 38 . Our unbiased mapping of ORs activated at different concentration of odors revealed the identities of more sensitive ORs as well as additional ORs activated by a higher odor concentration in freely behaving mice (Figs. 2 and 7) . Our approach could allow future studies to address the roles of each of the active ORs in odor detection and perception.
We found that acetophenone and TMT activated a large set of 48 and 21 ORs, respectively. Six ORs were activated by both odorants, raising the possibility that these ORs are broadly tuned, which could be determined in the future with an expanded range of odors. Unlike acetophenone and TMT, some odors, such as muscone, however, may only activate a few ORs 15, 24 . Following with the logic of narrowly tuned and broadly tuned ORs 4, 10, 11, 13, 39, 40 , the number of ORs activated by different odorants may vary markedly.
Although the overall sequences of acetophenone and TMT ORs are diverse, we identified residues that are similar in the two types of ORs to their respective activating odors, the majority of which were unique npg a r t I C l e S to and non-overlapping between the ORs of each tested odor. Most of these conserved residues are located at the transmembrane domains implicated in ligand binding. Furthermore, principal component analysis performed on OR sequences suggests that OR protein sequences contain information about their responsiveness to acetophenone. To further pursue the relationship between OR sequence and responsiveness, we developed models using two independent approaches that both predict whether or not a given OR responds to acetophenone based on its primary sequence information. The shared residues may directly or indirectly contribute to ligand selectivity of the ORs. One possibility is that ORs activated by the same odor form a similar binding pocket even though the overall sequences are different. On the other hand, multiple unrelated binding pockets could accommodate the same molecule. As structural information of ORs is currently lacking, molecular modeling studies should help to answer the question of how ORs with diverse structures can interact with the same odor ligand. Our receptor-based informatics studies will complement ligand-based chemoinformatics studies 41 to help understand how odors and ORs interact.
In summary, odor-induced S6 phosphorylation in activated OSNs, pS6-IP RNA-Seq, the 'one neuron-one receptor' rule and in vitro validation enable us to efficiently and comprehensively identify ORs responsive to specific odor stimuli in awake, behaving animals. OR mapping for additional odors is likely to guide deeper understanding of olfactory information coding.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Animals. WT C57BL/6 mice were purchased from Jackson. Animals of either sex were used at the age of 3-4 weeks. The procedures of animal handling and tissue harvesting were approved by the Institutional Animal Care and Use Committee of Duke University. odor stimulation. 3-4-week-old C57BL/6 mice (Jackson Labs) were placed individually into sealed containers (volume ≈ 2.7 l) inside a fume hood and allowed to rest for 1 h in an odorless environment. For odor stimulus, 10 µl of odor solution or 10 µl of distilled water (control) was applied to 1-cm × 1-cm filter paper held in a cassette (Tissue-Tek). The cassette was placed into a new mouse container into which the mouse was also transferred, and the mouse was exposed to the odor solution or control for 1 h. Experiments were performed in triplicates or quadruplicates, and within each replication the experimental and control mice were littermates of the same sex.
pS6-IP from the oe. pS6-IP was conducted as described with modifications 17 . The pS6 240-containing peptide that was used by Knight et al. 17 to improve signal-noise ratio was not included in our protocol because we observed relatively low pS6 background in the OE, and pilot experiments with the peptide significantly decreased the RNA yield. Following odor stimulation, the mouse was killed and the OE was dissected in 25 ml of dissection buffer (1× HBSS (Gibco, with Ca 2+ and Mg 2+ ), 2.5 mM HEPES (pH 7.4 adjusted with KOH), 35 mM glucose, 100 µg ml −1 cycloheximide, 5 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 1 mM beta-glycerophosphate) on ice. The dissected OE was transferred to 1.35 ml of homogenization buffer (150 mM KCl, 5 mM MgCl 2 , 10 mM HEPES (pH 7.4 adjusted with KOH), 100 nM Calyculin A, 2 mM DTT, 100 U ml −1 RNasin (Promega), 100 µg ml −1 cycloheximide, 5 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, protease inhibitor (Roche, 1 tablet per 10 ml)) and homogenized three times at 250 rpm and nine times at 750 rpm (Glas-Col). The homogenate was transferred to a 1.5-ml lobind tube (Eppendorf), and centrifuged at 2,000g for 10 min at 4 °C. The supernatant was then transferred to a new 1.5-ml lobind tube, to which 90 µl 10% NP-40 (vol/vol) and 90 µl 300 mM DHPC (Avanti Polar Lipids) were added. The mixture was centrifuged at 17,000g for 10 min at 4 °C. The supernatant was transferred to a new 1.5-ml lobind tube, and mixed with 20 µl pS6 antibody (Cell Signaling, #2215). Antibody binding was allowed by incubating the mixture for 1.5 h at 4 °C with rotation. During antibody binding, Protein A Dynabeads (Invitrogen, 100 µl per sample) was washed three times with 900 µl beads wash buffer 1 (150 mM KCl, 5 mM MgCl 2 , 10 mM HEPES (pH 7.4 adjusted with KOH), 0.05% BSA (wt/vol), 1% NP-40). After antibody binding, the mixture was added to the washed beads and gently mixed, followed by incubation for 1 h at 4 °C with rotation. After incubation, the RNA-bound beads were washed four times with 700 µl beads wash buffer 2 (RNase-free water containing 350 mM KCl, 5 mM MgCl 2 , 10 mM HEPES (pH 7.4 adjusted with KOH), 1% NP-40, 2 mM DTT, 100 U ml −1 recombinant RNasin (Promega), 100 µg ml −1 cycloheximide, 5 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 1 mM beta-glycerophosphate). During the final wash, beads were placed onto the magnet and moved to room temperature. After removing supernatant, RNA was eluted by mixing the beads with 350 µl RLT (Qiagen). The eluted RNA was purified using RNeasy Micro kit (Qiagen). Chemicals were purchased from Sigma if not specified otherwise.
cdnA synthesis, PcR amplification and library preparation for nextgeneration sequencing. RT-PCR from a small amount of RNA was conducted as described 9 with modifications. Briefly, 1.5 µl purified RNA was mixed with 5 µl reaction mix (1× PCR buffer (Roche), 1.5 mM MgCl 2 , 50 µM dNTPs, 2 ng µl −1 poly-T primer (TAT AGA ATT CGC GGC CGC TCG CGA TTT  TTT TTT TTT TTT TTT TTT Reads mapping and test for enrichment. Short reads were aligned to the mouse reference genome mm10 using Bowtie 42 . The reads mapped to annotated genes were then counted using BEDTools 43 . Because (to date) the UTRs of many ORs are not well defined, we only used the coordinates of coding exons for all the genes to count the mapped reads. Because the similarity between ORs can result in multiple alignments, we implemented a stepwise mapping scheme that allows reads aligned to multiple regions to be distributed proportionally to these regions based on the previous read counts from these regions 44 . Briefly, the reads were aligned to mm10 by Bowtie with −m 20 −a (reports all reads that map to at most 20 different regions on the reference genome), and the resulting mapping file was separated into 20 sub-files that included reads mapped only to 1, 2, …, 20 regions respectively. BEDTools was used to first count reads mapped to coding exons of genes using only uniquely mapped reads. Reads mapped to two regions were distributed based on read counts from uniquely mapped reads. For example, if a read was mapped to two different genes, and the read counts of these two genes were 3 and 7, respectively, based on uniquely mapped read counts, then 0.3 and 0.7 were added to the previous read counts and the new counts became 3.3 and 7.7. The iteration was allowed for 20 cycles and the resulted read counts were then rounded. Iteration number 20 was chosen because pilot parameter tuning indicated that the majority of read counts stopped increasing after 20 cycles.
The read counts table for all the genes were then imported into R and analyzed using the negative-binomial model based tool EdgeR 45 . A similar result was obtained using a separate tool DESeq2 employing similar model assumptions 46 . Littermate information was included in the design matrix to enhance the power of detection 47 . Multiple comparison was adjusted within the detected OR group by controlling FDR 48 . DESeq was used to calculate the size factors of individual libraries 46 .
dnA and vector preparation. The open reading frames of ORs were amplified using Phusion polymerase (Finnzymes) following manufacturer's protocols. Amplified fragments were cloned into pCI (Promega) or Rho-pCI for sequence verification. Unless otherwise noted, ORs were cloned into Rho-pCI to introduce a Rho-tag (first 20 amino acids of rhodopsin) at the N-termini. The Rho-tag is known to facilitate the heterologous expression of ORs 23 .
cell culture. Hana3A cells 9 were maintained in minimal essential medium (MEM) containing 10% FBS (vol/vol) with penicillin-streptomycin and amphotericin B, at 37 °C and 5% CO 2 .
dual-glo assay. The Dual-Glo assay for ORs was performed as described previously 26 . Briefly, Hana3A cells were plated on 96-well plates. 18-24 h after plating, cells were transfected with plasmids coding for OR, M3-R, RTP1S, CRE-luciferase and pRL-SV40. 18-24 h later, cells were stimulated by incubation with odorants diluted in CD293 for 4 h at 37 °C and 5% CO 2 to allow for CRE-luciferase expression. Luciferase and Renilla luciferase activities were measured using Dual-Glo kit following manufacturer's protocols (Promega). For dose-response curves, the background Renilla luciferase activity was subtracted from each data set. For fold of induction, the fold of signal increase was scaled so that luciferase measurements from cells transfected with empty vector was 0, and positive control (Olfr1126) 100. Data was analyzed using GraphPad Prism 5 or custom R scripts. The cut-off to determine positive or negative for in vitro responses to acetophenone was constructed as follows: A two-component Gaussian mixture model was used to fit the fold of luciferase activity increase at 300 µM acetophenone stimulation. The cut-off was chosen such that it excluded 99% of the Gaussian component that represents the non-responding group. When dose-response npg curves with a wide range of stimulation concentrations were available (Fig. 4) , we defined positive in vitro responses as the lower bounds of the 95% confidence intervals of the estimated maximum responses above 0. ORs with small response amplitude were independently confirmed by additional experiments using 10 −5.5 , 10 −5 , 10 −4.5 , 10 −4 , 10 −3.5 , and 10 −3 M acetophenone concentrations for stimulation.
Protein sequence analysis of acetophenone oRs. 1,090 mouse OR protein sequences (pseudogenes with one or more predicted transmembrane regions disrupted were excluded from the analysis) were aligned by Clustalx with manual adjustments. To identify residues that were more conserved among the acetophenone ORs than by chance, we first simulated the distributions of mean Grantham distances within random OR sets for each residue in the alignment. To simulate these distributions, 48 random ORs were randomly sampled from the mouse OR repertoire. At each amino acid residue, the pairwise Grantham distances across these 48 ORs were calculated and their mean was computed. Random sampling was iterated 20,000 times. The per-residue mean Grantham distances were also computed for the group of 48 acetophenone ORs, and used to find p-values under the null-hypothesis that they were samples from the distributions of random OR sets. Locations with gaps for more than 10% of the ORs were excluded from the study. Multiple comparison was adjusted by controlling FDR 48 . Visualization of residue frequencies was generated by WebLogo 49 .
SVM and logistic regression with elastic net penalty were used to build models using OR sequence properties to predict responsiveness to acetophenone. Using the aforementioned multiple alignment of mouse OR proteins, we calculated amino acid properties (polarity, composition and volume) as defined by Grantham 29 for 291 amino acid residues common to at least 10% of the ORs, resulting in 3 × 291 = 873 predictors. The missing values in this matrix (0.17%) resulting from occasional gaps in alignment were imputed from column means. To construct 0-1 responses, we used ORs that were supported by both in vivo and in vitro evidence, with the 48 ORs that were enriched in our pS6 RNA-Seq and responded to acetophenone in vitro labeled as 1's, and 367 ORs that were not enriched in pS6 RNA-Seq (P > 0.05 in both 1% and 100% acetophenone stimulation experiments) and did not respond to acetophenone in vitro labeled as 0's. Elastic net logistic regression was performed using the glmnet package 50 . SVM was performed using the e1071 package. A tenfold cross-validation scheme was performed on the mouse OR data. Each time, the data was divided into two subsets, for 100 iterations: 90% as training subset and 10% as testing subset. Logistic regression and SVM models were trained using the training set, before trained models were asked to predict the testing set and the predictions were compared with truth. True positive and false positive rates were calculated at all possible cut-offs to generate the ROC curves and AUC. Parameters (γ = 0.001, cost = 10 for RBF kernel SVM; α = 0.07 for elastic net logistic regression) were tuned by grid search. External validation was performed using 27 human ORs that could be functionally expressed in our heterologous system. Fluorescent in situ hybridization (FISH) was performed to detect the mRNA of the OR of interest, followed by immunohistochemical staining for pS6 induction. In situ hybridization was carried out as previously described 9 . Briefly, digoxigenin (DIG)-labeled complementary RNA probes were hybridized overnight at 58 °C to target mRNAs in 20-µm frozen tissue sections of the olfactory epithelium. After washing, the sections were incubated with a horseradish peroxidase (HRP)-conjugated antibody against DIG (Roche). Hybridization signals were detected using tyramide signal amplification (TSA) using fluorescein (PerkinElmer) as the fluorophore. Following FISH, staining for pS6 induction was performed as described above.
pS6 signal intensities were quantified as follows. Z-stacked images with 2-µm intervals between each slice, were obtained at 200× magnification using the Zeiss Axiocam MRm and upright inverted fluorescent microscope with ApoTome functionality to take optical sections that reduced background fluorescence. The filter sets used were as follows: Zeiss filter set #38 for fluorescein, #43 for Cy3, and #49 for bisbenzimide. Following acquisition, the OR signal was merged as a maximum intensity projection in ImageJ, and each OR area was selected manually. For each slice in a Z-stacked image, the average intensity of the pixels of a selected OR area was multiplied by the area in arbitrary square units to yield an integrated density value. The maximum integrated density measurement among the Z-stacks for the selected OR area was used for signal intensity quantification. The pS6 signal was merged as a maximum intensity projection, and used for measuring the average fluorescence of the entire olfactory epithelium. The corrected total cell fluorescence was calculated as Whole-cell signal = maximum integrated density of a cell Background signal = average signal per pixel for the entire olfactory epithelium Corrected total cell fluorescence = Whole-cell signal -(area of selected cell × background signal)
A Supplementary methods checklist is available.
